Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
11
NCT03391232
PolyPEPI1018 Vaccine and CDx for the Treatment of Metastatic Colorectal Cancer (OBERTO)
Phase: Phase 1/2
Role: Collaborator
Start: May 3, 2018
Completion: Jul 17, 2019